Thursday, November 12, 2026

EUR/CHF Is 4% Down In The Last 21 Sessions

EUR/CHF Is 4% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 4.23% for the last 21 sessions. At 21:06 EST on Wednesday, 19 June, EUR/CHF (EURCHF) is $0.95.

EUR/CHF's yearly highs and lows, it's 5.183% up from its 52-week low and 4.35% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.33%, a negative 0.16%, and a positive 0.27%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.43% (last week), 0.28% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy flat lines above mid-157.00s amid softer usd, bullish potential seems intact. According to FXStreet on Tuesday, 18 June, "This keeps the US Dollar (USD) bulls on the defensive for the second straight day and turns out to be a key factor acting as a headwind for the USD/JPY pair. ", "The USD/JPY pair struggles to capitalize on its gains registered over the past three days and oscillates in a narrow trading band, just above mid-157.00s during the Asian session on Tuesday. "
  • Usd/jpy price analysis: advances steadily yet consolidates below 158.00. According to FXStreet on Tuesday, 18 June, "The uptrend in the USD/JPY remains, though price action suggests that buyers remain cautious on Japanese intervention woes. ", "If USD/JPY climbs above 158.00, the next resistance level would be the 158.25 high hit on June 17, followed by the April 26 peak at 158.44. "
  • Usd/jpy flat lines below 158.00, bulls turn cautious amid subdued USD price action. According to FXStreet on Wednesday, 19 June, "The USD/JPY pair is seen oscillating in a narrow band during the Asian session on Wednesday and currently trading just below the 158.00 round-figure mark. ", "This, however, does little to impress the JPY bulls or provide any meaningful impetus to the USD/JPY pair, though subdued US Dollar (USD) price action continues to act as a headwind for spot prices."
  • Usd/jpy price analysis: steadies as asian session begins, above 158.00. According to FXStreet on Wednesday, 19 June, "Conversely, sellers can challenge key support levels if USD/JPY drops below 157.00. ", "Those reasons justify further USD/JPY upside, but fears that Japanese authorities might intervene in the markets keep traders cautious, with the major advancing steadily."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com